Unknown

Dataset Information

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.


ABSTRACT: Patients with diffuse large B cell lymphoma (DLBCL) exhibit marked diversity in tumor behavior and outcomes, yet the identification of poor-risk groups remains challenging. In addition, the biology underlying these differences is incompletely understood. We hypothesized that characterization of mutational heterogeneity and genomic evolution using circulating tumor DNA (ctDNA) profiling could reveal molecular determinants of adverse outcomes. To address this hypothesis, we applied cancer personalized profiling by deep sequencing (CAPP-Seq) analysis to tumor biopsies and cell-free DNA samples from 92 lymphoma patients and 24 healthy subjects. At diagnosis, the amount of ctDNA was found to strongly correlate with clinical indices and was independently predictive of patient outcomes. We demons

SUBMITTER: Scherer F 

PROVIDER: S-EPMC5490494 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature